Knight Therapeutics had a revenue of 92.26M in the quarter ending Sep 30, 2024, with -3.46%. This bring the company's revenue in the last twelve months to 348.64M, Decreased 3.19%. In the fiscal year ending Dec 31, 2023, Knight Therapeutics had annual revenue of 328.20M with 11.80% growth.